홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 메디컬디바이스 > 카테터 > U.S. Market for Drug-Eluting & Bare Metal Stents 2009
카테고리
메디컬디바이스 (4663)
내시경 (161)
분자영상/조영제 (28)
심혈관장치 (336)
안과기기 (102)
의료용 영상진단장치 (416)
의료용 일회용품 (77)
정형외과 (340)
창상관리 (163)
체외진단장치(IVD) (520)
초음파 (55)
치과기기 (176)
카테터 (239)
핵의료 (76)
헬스케어 IT (315)
환자모니터링 (390)
CT/MRI/X-ray (173)
시장보고서

U.S. Market for Drug-Eluting & Bare Metal Stents 2009

리서치사 iData Research Inc.
발행일 2009년 05월 상품코드 83462
페이지 정보 65 Pages
가격
US $ 3,995 ￦ 4,760,000 Hard Copy
US $ 4,495 ￦ 5,355,700 PDF by E-mail (Single User License)
US $ 4,995 ￦ 5,951,500 PDF by E-mail (Corporate License)

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템) 장착 PDF파일로, 2대의 PC까지 다운로드 하여 이용 가능합니다.
기타 자세한 사항은 문의하여 주시기 바랍니다.

영문목차

Abstract

In 2008, the U.S. market for drug eluting stents was valued at $1.95 billion, representing an increase of 1.6% over 2007. Overall average selling prices are predicted to decrease over the forecast period. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.

Table of Contents

U.S. MARKET FOR DRUG-ELUTING AND BARE METAL STENTS 2009

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
  • 1.2 BARE-METAL AND DRUG-ELUTING STENTS
  • 1.3 PTCA AND CUTTING BALLOONS
  • 1.4 BALLOON-INFLATION SYRINGES AND ANGIOPLASTY KITS
  • 1.5 INTERVENTIONAL CATHETERS
  • 1.6 INTERVENTIONAL GUIDEWIRES
  • 1.7 EMBOLIC PROTECTION DEVICES
  • 1.8 ATHERECTOMY DEVICES
  • 1.9 THROMBECTOMY DEVICES
  • 1.10 CHRONIC TOTAL OCCLUSION CROSSERS
  • 1.11 INTRODUCER SHEATHS
  • 1.12 VASCULAR CLOSURE DEVICES
  • 1.13 DIAGNOSTIC CORONARY CATHETERS AND GUIDEWIRES
  • 1.14 FRACTIONAL FLOW RESERVE GUIDEWIRES
  • 1.15 IVUS CATHETERS
  • 1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
  • 1.17 VULNERABLE PLAQUE DEVICES
  • 1.18 PFO, ASD AND VSD DEVICES
  • 1.19 PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
  • 1.20 AORTIC HEART VALVE REPLACEMENT DEVICES
  • 1.21 LEADING COMPETITORS

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA' S 9-STEP METHODOLOGY
    • 2.2.1 Step 1: Project Initiation & Team Selection
    • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
    • 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
    • 2.2.4 Step 4: Performing Primary Research
    • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
    • 2.2.6 Step 6: Market Forecast and Analysis
    • 2.2.7 Step 7: Identify Strategic Opportunities
    • 2.2.8 Step 8: Final Review and Market Release
    • 2.2.9 Step 9: Customer Feedback and Market Monitoring

BARE-METAL AND DRUG-ELUTING STENTS

  • 3.1 INTRODUCTION
  • 3.2 POPULATION AT RISK
  • 3.3 PROCEDURE NUMBERS
  • 3.4 MARKET ANALYSIS & FORECAST
    • 3.4.1 Units Sold by Type
    • 3.4.2 Bare-Metal Stent Market
      • 3.4.2.1 Bare-Metal Stent Market Drivers
      • 3.4.2.2 Bare-Metal Stent Market Limiters
    • 3.4.3 Drug-Eluting Stent Market
      • 3.4.3.1 Drug-Eluting Stent Market Drivers
      • 3.4.3.2 Drug-Eluting Stent Market Limiters
    • 3.4.4 Stents in Development
      • 3.4.4.1 Bioabsorbable Stents
      • 3.4.4.2 Bifurcated Stents
  • 3.5 STENT MARKET BY DELIVERY PLATFORM
  • 3.6 STENT MARKET BY SIZE
  • 3.7 COMPETITIVE ANALYSIS
    • 3.7.1 Bare-Metal Stents
    • 3.7.2 Drug-Eluting Stents
    • 3.7.3 Potential New Market Participants

ABBREVIATIONS

LIST OF FIGURES

  • EXECUTIVE SUMMARY
  • RESEARCH METHODOLOGY
  • BARE-METAL AND DRUG-ELUTING STENTS
  • Figure 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005- 2015
  • Figure 4-2: Angiography and Angioplasty Procedures, U.S., 2005 - 2015
  • Figure 4-3: Market for Coronary Stents by Type, U.S., 2005 - 2015
  • Figure 4-4: Units Sold, Market for Coronary Stents, U.S., 2005 - 2015
  • Figure 4-5: Coronary Stent Units by Type, U.S., 2005 - 2015
  • Figure 4-6: Market for Bare-Metal Stents, U.S., 2005 - 2015
  • Figure 4-7: Market Drivers and Limiters, Market for Bare-Metal Stents, U.S., 2008
  • Figure 4-8: Market for Drug-Eluting Stents, U.S., 2005 - 2015
  • Figure 4-9: Market Drivers and Limiters, Market for Drug-Eluting Stents, U.S., 2008
  • Figure 4-10: Coronary Stent Platforms in Development Not Approved by the FDA, 2008
  • Figure 4-11: Potential Market for Bioabsorbable Stents, U.S., 2013 - 2015
  • Figure 4-12: Potential Market for Bifurcated Stents, U.S., 2010 - 2015
  • Figure 4-13: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 - 2015
  • Figure 4-14: Market for Coronary Stents by Size, U.S., 2008
  • Figure 4-15: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
  • Figure 4-16: Leading Competitors, U.S. Market for Drug-Eluting Stents, 2008
  • ABBREVIATIONS

LIST OF CHARTS

  • EXECUTIVE SUMMARY
  • Chart 1-1: Market for Interventional Cardiology Devices, U.S., 2008
  • Chart 1-2: Market for Coronary Stents, U.S., 2005 - 2015
  • Chart 1-3: Coronary Atherectomy Devices Market, U.S., 2005 - 2015
  • Chart 1-4: Coronary CTO Crosser Market, U.S., 2005 - 2015
  • Chart 1-5: Coronary Vascular Closure Devices, U.S., 2005 - 2015
  • Chart 1-6: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 - 2015
  • Chart 1-7: Penetration Rate of FFR Guidewires in PCI Procedures, U.S., 2005 2015
  • Chart 1-8: Number of IVUS Catheter Units Sold, U.S., 2005 - 2015
  • Chart 1-9: Optical Coherence Tomography Catheter Market, U.S., 2010 - 2015
  • Chart 1-10: Leading Competitors, Market for Interventional Cardiology, U.S., 2008
  • RESEARCH METHODOLOGY
  • BARE-METAL AND DRUG-ELUTING STENTS
  • Chart 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005 - 2015
  • Chart 4-2: Age Group Most Likely to Undergo Cardiac Intervention: 60 to 69 Years Old, U.S., 2005 - 2015
  • Chart 4-3: Angioplasty and Angiography Procedures, U.S., 2005 - 2015
  • Chart 4-4: Market for Coronary Stents by Type, U.S., 2005 - 2015
  • Chart 4-5: Coronary Stent Units by Type, U.S., 2005 - 2015
  • Chart 4-6: Market for Bare-Metal Stents, U.S., 2005 - 2015
  • Chart 4-7: Market for Drug-Eluting Stents, U.S., 2005 - 2015
  • Chart 4-8: Penetration Rate for Bioabsorbable Stents, U.S., 2013 - 2015
  • Chart 4-9: Penetration Rate for Bifurcated Stents, U.S., 2010 - 2015
  • Chart 4-10: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 - 2015
  • Chart 4-11: Market for Coronary Stents by Size, U.S., 2008
  • Chart 4-12: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
  • Chart 4-13: Leading Competitors, Market for Drug-Eluting Stents, U.S., 2008
  • ABBREVIATIONS
Back to Top